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Abstract
Xenopus laevis early development is characterized by rapid and synchronous cleavage cycles, which consist of alternating S and M
phases. At midblastula transition, zygotic transcription begins and these cleavage cycles are replaced by longer cell division cycles that
include gap phases and checkpoints. Herein, we demonstrate developmentally regulated Cdc6 isoform switching that contributes to this
developmental cell cycle remodeling. Cdc6 is an essential component of the eukaryotic DNA replication machine that licenses each origin
to one round of DNA replication each cell division cycle. The originally characterized Xenopus Cdc6 isoform (here termed Xcdc6A) and
a novel isoform (Xcdc6B) have divergent N-terminal regulatory regions and different temporal patterns of expression. Although abundant
in the early embryo, Xcdc6A becomes undetectable following midblastula transition. In contrast, while Xcdc6B is present in the early
embryo, it is nonfunctional, as judged by lack of chromatin binding. In somatic tissue, however, Xcdc6B binds chromatin and its inhibition
blocks entry into S phase. This is the first example of developmental regulation of Cdc6, raising intriguing implications for cell cycle
remodeling during embryogenesis.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The transition from an early embryonic to a somatic cell
involves significant cell division cycle remodeling. For ex-
ample, in Xenopus laevis, the first 12 divisions (0–6 h after
fertilization) comprise the cleavage divisions, which are
independent of zygotic transcription and cellular growth
(Masui and Wang, 1998; Newport and Kirschner, 1982).
These cleavage divisions are characterized by rapid (30
min) and nearly synchronous oscillations between S and M
phases, with no detectable gap phases. At the midblastula
transition (MBT; stage 8, 5 h after fertilization), the cell
division cycle lengthens and zygotic transcription increases
10- to 100-fold (Newport and Kirschner, 1982). During
gastrulation (stages 10–13, 8–16 h after fertilization), de-
struction of several maternal cell cycle regulators occurs
(Hartley et al., 1997; Howe et al., 1995; Howe and Newport,
1996; Kim et al., 1999) and the more typical somatic cell
division cycle (G1-S–G2-M) is established. Following gas-
trulation, the cell divisions are cell-autonomous and asyn-
chronous, resulting in mitotically active and inactive do-
mains within the embryo (Saka and Smith, 2001). One
dramatic developmental shift from embryonic to somatic
cell division cycles occurs during S phase, which can last a
few minutes in pre-MBT embryonic cells to several hours in
somatic cells. The length of S phase is modulated by de-
creasing the number of sites at which DNA replication
initiates, rather than slowing the speed with which the rep-
lication forks move (Walter and Newport, 1997). An attrac-
tive hypothesis to explain this change in replicon size in-
vokes a developmentally triggered change in one or more
components of the DNA replication machinery.
While the nature of this trigger is to date unknown, the
molecular machinery that initiates DNA replication is
highly conserved among all eukaryotes and is activated in at
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least three steps. In the first step, trans-acting factors bind to
cis-acting DNA sequences (origins of replication) to assem-
ble what has been termed the prereplication complex (pre-
RC). These trans-acting factors bind to DNA sequentially
and include the origin recognition complex (ORC), Cdc6,
Cdt1, and the minichromosome maintenance (MCM) pro-
teins (reviewed in Bell and Dutta, 2002). ORC, an assembly
of six proteins, recruits both Cdc6 and Cdt1 to the DNA.
Cdc6 and Cdt1 are both required to load the MCMs, a
ring-shaped complex comprised of six subunits, around the
DNA to form the pre-RC. In the second step, the prerepli-
cation complex is activated and the complementary strands
of DNA unwind. The transition between these two steps
involves a unidirectional switch, or licensing factor, which
can be productively utilized only once each S phase. Li-
censing factor is composed of a number of components,
including Cdc6. The process by which each origin is fired
only once each S phase, termed the “block to rereplication,”
is a fundamental feature of all eukaryotes and assures that
no part of the genome is reduplicated. In the third step,
DNA synthesis is initiated on one or both strands. Recent
work in many laboratories indicates that both the molecular
components that initiate DNA replication and the step
through which they are activated are conserved from yeast
to human (Bell and Dutta, 2002).
Since all eukaryotic DNA replication initiates only from
fully assembled pre-RCs, variation in any of the pre-RC
components could modulate the change in replicon size
observed during developmental cell division cycle repro-
gramming. The Cdc6 protein is an especially attractive
candidate for such a developmental switch, since budding
yeast Cdc6 is an essential determinant of origin specificity
(Mizushima et al., 2000) and Xenopus Cdc6 (Xcdc6) facil-
itates the binding of ORC to somatic cell chromatin (Sun et
al., 2002). In the current study, we demonstrate that the
originally characterized Xcdc6 (now termed Xcdc6A) is not
detectable in somatic tissue and is replaced by a novel
isoform (Xcdc6B). Like other metazoan Cdc6 orthologs,
Xcdc6B enters the nucleus and binds chromatin in a cell
cycle-dependent manner and restores DNA replication in a
Cdc6-depleted egg extract. However, Xcdc6A and Xcdc6B
have divergent N-terminal regulatory regions and distinct
temporal patterns of expression. Strikingly, we find that
Xcdc6A protein levels plummet during gastrulation and are
undetectable beyond stage 12. Concomitant with this rapid
loss of Xcdc6A protein, we observe a corresponding in-
crease in Xcdc6B protein levels. Moreover, although
Xcdc6B is present in the egg, it does not appear to partic-
ipate in initiating S phase in the initial cleavage divisions. In
somatic tissue, however, inhibition of Xcdc6B blocks entry
into S phase. Finally, while Xcdc6A protein levels remain
constant during the early embryonic cell cycles, Xcdc6B
protein levels decline following mitosis during somatic cell
cycles. Together, these findings suggest that Xcdc6A func-
tions only as an embryonic Cdc6 isoform. Later in devel-
opment, Xcdc6B replaces Xcdc6A and ultimately becomes
the only Cdc6 isoform expressed in somatic tissue. This is
the first demonstration of developmentally regulated Cdc6
isoforms, whose expression pattern may contribute to the
dramatic cell division cycle remodeling known to occur
during Xenopus development.
Materials and methods
Isolation of a cDNA encoding Xenopus Cdc6B
To isolate a second Xcdc6 homologue, we performed
low stringency hybridization screening of a Xenopus so-
matic (stage 30, distinct tailbud) lambda cDNA library
(Stratagene) using an 470-bp internal fragment of
Xcdc6A (sequences encoding residues 17–332, comprising
the highly conserved clamp loader domain found in all Cdc6
orthologs; Lui et al., 2000). A full-length clone, which was
distinct from Xcdc6A, was selected for further study and
sequenced on both strands by standard methods.
Embryo, tissue, and cell culture protein lysates
Frogs were injected with 800 IU chorionic gonadotropin
and maintained for 10 h in 0.08 M NaCl. Freshly laid eggs
were fertilized and maintained in 0.1MBS (8.8 mM NaCl,
0.1 mM KCl, 0.1 mM MgSO4, 0.5 mM Hepes, pH 7.8, 0.25
mM NaHCO3) for 30 min, dejellied with 2% cysteine (pH
7.8), and returned to 0.1 MBS for development. Embryo
staging was performed by using a Leica MZ6 dissecting
microscope and standard procedures (Nieuwkoop and
Faber, 1994). Embryos, Xenopus adult tissues, or Xenopus
tissue culture (XTC) cells were disrupted in extraction
buffer (80 mM -glycerol phosphate, pH 7.3, 20 mM
EGTA, 15 mM MgCl2, 0.1% TX-100), clarified (Beckman
Microfuge E, 14000 rpm, 5 min), drop-frozen in liquid
nitrogen, and stored at –70°C.
Total RNA isolation and reverse transcription–polymerase
chain reaction (RT-PCR)
Total RNA was extracted from 10 embryos of each stage,
1  106 XTC cells, adult liver, or adult heart by using the
RNAqueous4PCR kit (Ambion). First-strand cDNA synthe-
sis was performed by using the SuperScript Preamplifica-
tion System (Gibco). Equal RNA (1 g) was used in each
reaction mix [0.5 g oligo(dT)12–18, 1 PCR buffer (20
mM Tris–HCl, pH 8.4, 50 mM KCl), 2.5 mM MgCl2, 0.01
mM DTT, 1 mM each dNTP, 200 units SuperScript IIRT].
Primers were selected to amplify uniquely either Xcdc6A or
Xcdc6B, and their specificity was assessed by using
Xcdc6A- and Xcdc6B-containing plasmids as templates in
parallel reactions. The forward primer for both Xcdc6A and
Xcdc6B was GGAATTCCACGATGGCAAGCACCAG-
GTCTCGG. The isoform-specific reverse primers were
TAGCTGGACCCCCACACTG (which amplifies a 440-bp
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fragment unique to Xcdc6A) and CCTTTCCTGCAGCCT-
GTGG (which amplifies a 416-bp fragment unique to
Xcdc6B). A 139-bp fragment of Xenopus -actin type 8 was
amplified as an internal reference in the same vessels with
either the Xcdc6A or Xcdc6B primer sets using forward
(TCTGTTGGCTTTGGGGTTCAGG) and reverse (TCAC-
CTACATAGCTGTCCTTCTGG) primers. Each RT-PCR
(25 l final volume) contained template (1 l of RT-PCR),
200 pmol of each primer, 200 pmol dNTP, 1 unit Advantage
Taq polymerase (Clontech), and 1 manufacturer’s buffer.
The reactions were prewarmed at 94°C for 2 min and cycled
20 times as follows: 94°C, 30 s; 62°C, 30 s; and 72°C, 30 s.
Positive and negative controls included plasmids containing
Xcdc6A, Xcdc6B, or no insert as template. Random se-
quencing of a subset of either Xcdc6A or Xcdc6B PCR
fragments confirmed the anticipated identity (data not
shown).
Expression and purification of recombinant Xcdc6
Recombinant full-length Xcdc6A and Xcdc6B proteins
were produced as glutathione S-transferase (GST) fusion
proteins (Furstenthal et al., 2001), expressed in BL21-
CodonPlus (Stratagene) bacteria, and purified as described
(Frolova et al., 2002). Protein concentrations were deter-
mined by using the Bio-Rad protein assay kit.
Antibody production
A peptide unique to Xcdc6B (ETPSGSRNHR-
LQERKTA, residues 122–138; Fig. 1A, black rectangle)
was conjugated to keyhole limpet hemocyanin and used to
immunize rabbits (Research Genetics). Polyclonal anti-
Xcdc6B peptide antibodies were purified by affinity chro-
matography on columns of Affi-Gel resin (Bio-Rad) con-
taining the covalently attached peptide (Kumagai and
Dunphy, 1992). Control experiments demonstrated that the
anti-Xcdc6B antibody staining was abolished by the pres-
ence of 1 mg/ml Xcdc6B peptide (data not shown).
Xenopus egg extracts, immunodepletions, and DNA
replication assays
Xenopus cytostatic factor (CSF)-arrested egg extracts
were prepared from unactivated eggs as described (Murray,
1991). Xenopus CSF-arrested extracts were supplemented
with demembranated sperm chromatin (600 nuclei/l for
replication assays, 3000 nuclei/l for chromatin blots), cy-
cloheximide (100 g/ml), and CaCl2 (0.4 mM). Immu-
nodepletions were performed on interphase extracts (15 min
postactivation) by using protein A-agarose containing either
affinity purified anti-Xcdc6 (Coleman et al., 1996) or con-
trol rabbit anti-mouse IgG (Zymed) antibodies (10 g an-
tibody/130 l extract). All experiments were performed by
using double-depleted extracts and efficient Xcdc6A/B re-
moval confirmed by immunoblot analyses (data not shown).
Replication of sperm chromatin was monitored by agarose
gel electrophoresis following labeling with [-32P]dCTP
(Dasso and Newport, 1990). Labeling was performed in
three time windows (e.g., amount of replication that oc-
curred in 0–45, 46–90, and 91–105 min) for each sample,
as indicated. Quantitation of replication assays was per-
formed by using a Phosphorimager (Fuji Instruments).
Chromatin immunoblots
Chromatin immunoblots were performed as described
for Xenopus low speed supernatants (Frolova et al., 2002;
Furstenthal et al., 2001) by using sperm chromatin as sub-
strate. Alternatively, chromatin immunoblots were also per-
formed on nuclei isolated from asynchronous or synchro-
nized XTC cells (see below). For these somatic cells, nuclei
were isolated by digitonin treatment (Gilbert et al., 1995;
Wu et al., 1997), extracted with TX-100, and pelleted
through sucrose (Frolova et al., 2002; Furstenthal et al.,
2001) in parallel with extract-treated sperm chromatin. Im-
munoblotting was performed by using anti-Xorc2 (Carpen-
ter et al., 1996), anti-Xcdc6 (Coleman et al., 1996), anti-
Xcdc6B, anti-Xmcm3 (Hua and Newport, 1998), and anti-
-tubulin (Sigma) antibodies and developed by using the
Renaissance chemiluminescence reagent (NEN).
In vitro dephosphorylation of Xcdc6B
XTC nuclei (1 105) were lysed in EB buffer containing
1 mM DTT, 0.5% TX-100, 1 mg/ml ovalbumin, and 10
g/ml each of pepstatin, chymostatin, and leupeptin. Nu-
clear lysates were then made 1 in NEBuffer 2 (50 mM
NaCl, 10 mM Tris–HCl, 10 mM MgCl2, 1 mM DTT, pH
7.9), 100 g/ml BSA, and incubated in the presence or
absence of calf intestinal phosphatase (10 U; New England
Biolabs). All reactions were incubated 30 min at 37°C,
resolved in 10% SDS–PAGE, and immunoblotted with anti-
Xcdc6B antibodies.
XTC cell synchronization
XTC cells were grown as monolayers in Xenopus
media supplemented with antibiotics (Penicillin, Kana-
mycin, Streptomycin, 50 ng/ml each) and 10% fetal bo-
vine serum in an incubator at 25°C. Cells were synchro-
nized in mitosis with nocodazol (NOC, 50 ng/ml) or in
G1/S by double thymidine block [sequential growth in
media supplemented with 2 mM thymidine (20 h), plain
media (15 h), and media supplemented with 2 mM thy-
midine (20 h)]. In some cases, G1/S arrested cells were
released into plain media for one or more hours. In these
cases, mitosis, early, and mid-G1 occurred at release
times of 16, 20, and 24 h, respectively.
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Immunofluorescence microscopy
Indirect immunofluorescence staining was performed as
described (Frolova et al., 2002; Herbig et al., 1999). Briefly,
cells were washed three times with PBS, fixed for 20 min
(3.5% formaldehyde in PBS), permeabilized with 0.2% Tri-
ton X-100 in 1 PBS for 20 min, and blocked in PBS
supplemented with 10% in FBS (F-PBS) for 1 h. GST and
Xcdc6B were detected by staining with anti-GST (1:200 in
F-PBS; Santa Cruz Biotechnology) or affinity purified anti-
Fig. 1. Two Cdc6 isoforms are present in X. laevis. (A) Identical residues between Xenopus Cdc6 members are boxed in black. Arrows indicate regions used
to design PCR primers specific for each Xcdc6 isoform. Black rectangle under sequence indicates Xcdc6B peptide region used as antigen to make antibodies
specific for Xcdc6B. Asterisks above sequence indicate the putative destruction box and KEN-box motifs. Sequence alignment was performed by multialign
Blosum 62 algorithm (Corpet, 1988). (B) Plot of percent altered residues (within arbitrary bins of 50 amino acids) between Xcdc6A and Xcdc6B proteins
along the length of Xcdc6. The proposed regulatory N-terminal domain (shaded bars) and the region with significant homology to the archaebacteria Cdc6
homologue (white bars, composed of the clamp loader and winged helix domains; Liu et al., 2000) are indicated in the schematic representation.
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Xcdc6B (1:200 in F-PBS) antibodies for 2 h. Cells were
then stained with AlexaFluor 488 goat anti-rabbit IgG con-
jugate (1:1000 in F-PBS; Molecular Probes) for 1 h. BrdU
incorporated into DNA was detected by staining with anti-
BrdU antibody (1:500 in F-PBS; Pharmingen) containing
125 U/ml benzon nuclease (Novagen) for 2 h, followed by
staining with AlexaFluor 594 goat anti-mouse IgG conju-
gate (1:500 in F-PBS; Molecular Probes). The cells were
then washed with PBS and stained with PBS containing
0.25 g/ml of Hoechst (Sigma) for 5 min. All antibody
incubations were done at room temperature. The coverslips
were mounted in 90% glycerol and viewed on a Nikon
Eclipse E800 equipped with a 60 objective. All images
were captured at identical magnification and exposure times
by using a Quantix cooled CCD camera (Photometrics) with
Isee software (Inovision).
XTC cell microinjections
To determine the optimal microinjection schedule, we
synchronized XTC cells in mitosis with 50 ng/ml NOC and
examined bromodeoxyuridine uptake at different times fol-
lowing replating. M phase took 2–3 h, G1 phase lasted
10–12 h, S phase peaked at 12–14 h post NOC block and
was completed by 12–13 h, G2 took 7–8 h indicated by the
appearance of mitotic cells. Cells were synchronized in G1
phase by one of two means. In the first, mitotic shake-off
cells were incubated on poly-lysine-coated coverslips for
6 h to ensure secure reattachment and entry into G1 phase.
In the second, cells on coverslips were microinjected in the
middle of the second thymidine block (10 h before release).
Both G1 phase synchronization schemes yielded essentially
identical results.
We downregulated Xcdc6B activity by microinjecting
one of two inhibitors. In one approach, we utilized morpho-
lino anti-sense oligos (MOs) (AATTCAGTCAGAAATA-
ACCAGGCTC) that targeted the 5 untranslated region of
Xcdc6B (52 to 27, relative to the ATG start site) to
inhibit Xcdc6B translation (Gene-tools). In a second ap-
proach, we microinjected affinity purified anti-Xcdc6B an-
tibodies to inhibit Xcdc6B activity. Control experiments
included microinjecting either buffer alone, standard control
MOs (CCTCTTACCTCATTACAATTTATA, Gene-tools;
a gift from J.-P. Saint-Janet, University of Pennsylvania
School of Veterinary Medicine), or rescuing the anti-
Xcdc6B MO phenotype by coinjecting both anti-Xcdc6B
MO along with recombinant Xcdc6B protein. All samples
for microinjection contained nonfused GST protein to detect
which cells were microinjected. Immediately prior to mi-
croinjection, each sample was filtered by centrifugation at
8000 rpm for 1–2 min at 4°C through a 0.22-m filter unit
(Ultrafree-MC, Millipore) and cleared by centrifugation at
14,000 rpm for 5 min at 4°C. Samples were injected into the
cytoplasm of cells (200 cells for each sample) by using
purchased needles (Femtotips, Eppendorf Scientific) with a
microinjector (model 5242; Eppendorf Scientific) and a
manipulator (model 5171; Eppendorf Scientific) mounted
on an inverted microscope (Nikon TE300). Following mi-
croinjection, cells were released from thymidine block in
plain media, which was supplemented with 10 M BrdU
and 1 M fluorodeoxyuridine (1:1000 dilution; Amersham).
Since this is a continuous flow microinjector, the volume
injected is dependent on how long the needle remains in a
given cell. It is impossible, therefore, to know the precise
amounts of injected material. Assuming 100% of the pro-
teins and/or oligos pass through the 0.22-m filter and
remain soluble during centrifugation, each injected cell
would contain approximately 1 g nonfused GST protein,
0.5 ng MOs (either anti-Xcdc6B or control), 0.3 ng GST-
Xcdc6B, or 40 pg of anti-Xcdc6B antibody.
XTC cell transfections
XTC cells were transfected by using the TransIT-TKO
reagent following the manufacturer’s instructions (Mirus).
Briefly, XTC cells were plated (50% confluence) on 35-mm
plates and cultured for 24 h prior to transfection. TransIT-TKO
reagent (4 l) was diluted with 100 l of serum-free Xenopus
media in the presence or absence of MOs and incubated for 20
min at room temperature. The diluted TransIT-TKO reagent/
DNA mix was then added to plates containing 1 ml of com-
plete Xenopus media, and cells were cultured for an additional
24 h. The relative concentrations of Xcdc6B, Xorc2, and -tu-
bulin were then determined by lysing the transfected cells in
SB (150 mM NaCl, 50 mM Tris, 1% NP-40) and immuno-
blotting equivalent protein loads, as described.
Results
Isolation of a second Xenopus Cdc6-like protein, Xcdc6B
In preliminary experiments using polyclonal antibodies
directed against the originally characterized Xcdc6 protein
(Coleman et al., 1996), we detected no immunoreactive
bands in somatic cell lysates but strong signals in oocyte
and egg extracts. This unexpected result led us to hypoth-
esize that an additional Xcdc6 isoform(s), which does not
cross react with our antibodies, might be present in somatic
tissue. To pursue this issue, we performed low stringency
hybridization screening of a Xenopus somatic (stage 30)
cDNA library. Out of approximately one-million colonies,
two classes of Cdc6-like genes were identified (Fig. 1A).
One class was essentially identical (both in protein-coding
and untranslated regions) to the previously identified iso-
form (Coleman et al., 1996; Tian et al., 1997) that was
isolated from oocyte libraries. Hereafter, we refer to this
isoform as Xcdc6A. Small differences in nucleic acid se-
quence within this class likely stem from the pseudotet-
raploid nature of X. laevis, wherein many genes are repre-
sented by multiple nearly identical copies.
The second class, hereafter referred to as Xcdc6B (Gen-
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Bank Accession No. AY222353), is 90% identical at the
amino acid level and 70% identical at the nucleic acid
level in the untranslated regions to the Xcdc6A isoform
(Fig. 1A). The numerous nucleic acid differences between
Xcdc6A and Xcdc6B indicate that they arose from separate
genes rather than via differential splicing. A survey of the
Xenopus EST database confirmed the presence of these two
Xcdc6 classes. Based on analysis of sequence, both Xcdc6A
and Xcdc6B have nearly identical molecular weights and
charges, and thus are not predicted to migrate differently
during one- or two-dimensional electrophoresis. Strikingly,
the major divergence between Xcdc6A and Xcdc6B is clus-
tered in an N-terminal extension which is thought to func-
tion as a regulatory region (Frolova et al., 2002). The pu-
tative destruction box and KEN-box motifs reside within
this N-terminal domain. Unlike Xcdc6A, Xcdc6B has an
intact KEN-box (Fig. 1A, asterisks), suggesting it may be
regulated in a cell cycle-dependent manner (see below).
Overall, the Xcdc6A and Xcdc6B N-terminal domains have
differences at 30% of the residues while the clamp loader
and winged helix domains, which are present in all Cdc6
orthologs (Liu et al., 2000), have differences at only 5%
of the residues (Fig. 1B).
Xcdc6A and Xcdc6B display different regulation during
development
Xcdc6A ESTs have been isolated from oocyte through
stage 10 libraries, while Xcdc6B ESTs have been isolated
only from libraries generated from stage 10 and beyond,
suggesting that Xcdc6B may replace Xcdc6A as develop-
ment progresses (data not shown). To determine the tem-
poral patterns of Xcdc6A and Xcdc6B expression, we per-
formed immunoblot and semiquantitative RT-PCR
analyses. A polyclonal antibody directed against the entire
Xcdc6A protein (Coleman et al., 1996) preferentially rec-
ognizes the Xcdc6A isoform (Fig. 2A, top) and detects a
prominent 61-kDa band in Xenopus interphase egg extracts,
but no polypeptides in somatic Xenopus tissue culture
(XTC) cell lysates (Fig. 2B, left). Similarly, although an-
other pre-RC protein (Xorc2) is present in approximately
constant amounts during development, Xcdc6A protein lev-
els plummet at the MBT (stage 8) and cannot be detected
following stage 12 (Fig. 2C). Interestingly, Xcdc6A mRNA
levels decrease following the MBT but remain detectable
until stage 40 (Fig. 2D), indicating that transcriptional con-
trol contributes only part of this regulation.
To assess Xcdc6B expression, we generated antisera
directed against a synthetic peptide unique to Xcdc6B (Fig.
1A, black rectangle). This antisera specifically recognizes
recombinant GST-Xcdc6B protein (Fig. 2A, bottom) and
weakly recognizes an 61-kDa polypeptide in Xenopus
interphase egg extracts and a prominent 63-kDa polypep-
tide in XTC cell lysates (Fig. 2B, right). By comparing the
Xcdc6B signal in Xenopus interphase egg extracts with
known concentrations of purified GST-Xcdc6B protein
(Fig. 2B, right, lanes 1 and 3–7, respectively), we estimate
the concentration of Xcdc6B in the early embryo to be 45
nM. In our initial characterization of Xcdc6A (Coleman et
al., 1996), we estimated its concentration to be80 nM. We
now know that this is an overestimate in view of the comi-
gration of the two Xcdc6 isoforms and cross-reactivity of
our anti-Xcdc6A antibody with Xcdc6B (Fig. 2A). The
concentration of Xcdc6A is likely in the 60–70 nM range,
indicating that both isoforms are present in the egg at
similar levels. In the early stages of Xenopus development,
Xcdc6B is present predominately as a 61-kDa form (Fig.
2C, bottom, lanes 1–4). Following MBT (stage 8), a 63-kDa
immunoreactive band is detected that increases in intensity
during development (Fig. 2C, bottom, lanes 6–15). This
change in relative mobility is due to phosphorylation since
phosphatase treatment of the 63-kDa Xcdc6B form in-
creases its mobility to 61 kDa (Fig. 2E). Finally, RT-PCR
analyses reveal that Xcdc6B mRNA is present at a relatively
constant level throughout development (Fig. 2D, bottom,
lanes 1–16) and easily detected in adult tissue (Fig. 2D,
bottom, lanes 17–18). Collectively, these data demonstrate
that Xcdc6 expression is regulated on multiple levels during
development and involves two isoforms which undergo
transcriptional, translational, and posttranslational regula-
tion.
Endogenous Xcdc6B is expressed and localized in a cell
cycle-dependent manner
Previous transfection studies have shown that human
Cdc6 shuttles between the nucleus and cytoplasm in a phos-
phorylation-mediated, cell cycle-dependent manner (Jiang
et al., 1999; Petersen et al., 1999; Saha et al., 1998). To
characterize the expression and cellular localization of
Xcdc6B during cell cycle progression, we performed indi-
rect immunofluorescence and immunoblot analyses on XTC
somatic cells that were synchronized by double thymidine
block and fixed at various times following release into
complete media supplemented with BrdU. As anticipated,
double thymidine blocked cells have not entered S phase, as
indicated by minimal BrdU uptake. Endogenous Xcdc6B
staining is weak and diffuse throughout G1/S cells, with a
concentration in the nucleolar regions (Fig. 3A, top). Fol-
lowing release into complete medium for 1 h, a significant
percentage of cells have entered S phase and Xcdc6B stain-
ing is concentrated in the nucleus (Fig. 3A, middle). Three
hours after release, essentially all the cells have entered S
phase but Xcdc6B staining is diminished with a concentra-
tion in the nucleoli (Fig. 3A, bottom).
Consistent with these immunofluorescence results, immu-
noblot analyses of synchronized XTC cell lysates reveal that,
while the levels of -tubulin are nearly constant, the levels of
Xcdc6B vary dramatically during the cell cycle (Fig. 3B). That
is, Xcdc6B levels are relatively low following mitosis through
mid-G1 but increase in abundance (5-fold) during the G1/S
transition and remain high through mid-S phase (Fig. 3B).
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Fig. 2. Xcdc6A and Xcdc6B have different expression patterns during development. (A) Purified GST-Xcdc6B (lanes 1 and 3) or GST-Xcdc6A (lanes 2 and
4) at the indicated concentrations were prepared for immunoblotting using anti-Xcdc6A (top) or anti-Xcdc6B (bottom) antibodies. Note that the polyclonal
antibodies directed against the entire Xcdc6A protein preferentially recognize the Xcdc6A isoform, while the anti-Xcdc6B peptide antibodies are specific for
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Finally, immunoblotting of subcellular fractions isolated from
synchronized XTC cells confirms the increase of Xcdc6B in
nuclear and chromatin regions during S phase (Fig. 3C). Col-
lectively, these data demonstrate that, like other somatic Cdc6
proteins, Xcdc6B expression and localization are regulated
during the cell cycle.
Xcdc6B chromatin binding is developmentally regulated
Since both Xcdc6A and Xcdc6B are present in the early
embryo at comparable levels, we next investigated whether
endogenous Xcdc6B contributes to DNA replication at this
time. For these experiments, we isolated detergent-extracted
chromatin that had been incubated for various times in an
undepleted Xenopus egg extract. As previously demon-
strated, both Xorc2 and Xcdc6A bind chromatin rapidly
(Fig. 4, top and middle, respectively). In contrast, no en-
dogenous Xcdc6B binds chromatin in an embryonic egg
extract (Fig. 4, bottom). Importantly, in control experiments
we detect either recombinant GST-Xcdc6B protein (Fig. 4,
lanes 1–4) or endogenous Xcdc6B in the cytosolic egg
Xcdc6B. (B) Xenopus interphase egg extract (lanes 1), somatic XTC cell lysates (lanes 2), or purified GST-Xcdc6B protein (1.25, 2.5, 5, 10, 20 ng; lanes
3–7, respectively) were prepared for immunoblotting with anti-Xcdc6A (left) or anti-Xcdc6B (right) antibodies. (C) Immunoblots were performed on lysates
isolated from staged Xenopus embryos (lanes 1–15), adult liver (lane 16), adult heart (lane 17), or XTC cells (lane 18). Embryo and adult tissue samples were
normalized for equivalent protein (1 embryo/lane; 100 g). Samples were prepared for immunoblot analysis by using anti-Xorc2 (top), anti-Xcdc6A
(middle), or anti-Xcdc6B (bottom) antibodies. (D) RT-PCR was performed on total RNA isolated from staged Xenopus embryos (lanes 1–16), adult liver (lane
17), or adult heart (lane 18) using primers specific for either Xcdc6A (top) or Xcdc6B (bottom). Actin served as an internal loading control and was amplified
in the same vessels and was present in approximately equal amounts under all conditions (top and bottom). Control reactions amplified in parallel include
Xcdc6A plasmid (lane 19), no template (lane 20), or Xcdc6B plasmid (lane 21). (E) Phosphatase treatment of the 63-kDa Xcdc6B isoform increases its
relative mobility to 61 kDa. XTC cell nuclear extracts were incubated in the absence (lane 1) or presence (lane 2) of alkaline phosphatase and prepared for
immunoblot analysis with anti-Xcdc6B antibodies.
Fig. 3. Endogenous Xcdc6B is regulated in a cell cycle-dependent manner in somatic cells: its abundance increases as cells enter S phase when it shuttles
into the nucleus and binds chromatin. (A) XTC cells were synchronized by double thymidine block, released into complete media supplemented with BrdU,
and either fixed immediately (top) or fixed following 1 h (middle) or 3 h (bottom) of chase. Fixed cells were stained for total DNA (left column), endogenous
Xcdc6B (middle column), or entry into S phase (right column). (B) Immunoblot analyses of total cell lysates isolated from synchronized XTC cells at the
indicated stages. Cells were synchronized by double thymidine block, and equivalent protein (50 g/lane) was prepared at different stages for immunoblot
analysis by using anti-Xcdc6B (top) or anti--tubulin (bottom) antibodies. (C) Nuclear (top) or chromatin (bottom) fractions were isolated from digitonin-
treated XTC cells that were isolated from asynchronous (lane 1), nocodazole-treated (lane 2), double thymidine-blocked (lane 3), or double thymidine-blocked
followed by a 1-h (lane 4) or 3-h (lane 5) chase in complete media. Samples were prepared for immunoblot analysis by using anti-Xcdc6B antibodies. Each
lane represents 2  105 nuclei.
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fraction (data not shown). Similarly, we can detect endog-
enous Xcdc6B in immunoblots of an equivalent number of
somatic nuclei or somatic chromatin (Fig. 3C). These results
argue that Xcdc6B does not function in the early embryo,
despite being present at relatively high concentrations.
Xcdc6B is a functional Cdc6 protein
To confirm Xcdc6B functionality, we next investigated
whether it would restore DNA replication to a Xcdc6-
depleted egg extract. Interphase egg extracts were immu-
nodepleted and the complete removal of both Xcdc6A and
Xcdc6B was confirmed by immunoblot analyses (data not
shown). As expected, in the absence of either Xcdc6A or
Xcdc6B, DNA replication is severely diminished relative to
a mock-depleted extract assessed in parallel (Fig. 5A, com-
pare lanes 1–3 with 16–18) and little Xmcm3 is loaded onto
DNA (Fig. 5C, lanes 1–3). In agreement with earlier work,
recombinant GST-Xcdc6A restores DNA replication (Fig.
5A and B, parts a and c) and recruits Xmcm3 to chromatin
(Fig. 5C, lanes 7–9). Like GST-Xcdc6A, GST-Xcdc6B
binds chromatin rapidly and loads Xmcm3 (Fig. 5C, lanes
4–6) but induces 1.5- to 2-fold lower DNA replication (Fig.
5A and B, compare a with b and c with d). The lower
activity of Xcdc6B is not a function of protein purification
as both GST-Xcdc6A and GST-Xcdc6B were induced/pu-
rified in parallel and multiple such inductions/purifications
yielded similar results. From these data, we conclude that
Xcdc6B can bind chromatin and restore DNA replication in
an embryonic egg extract in the absence of Xcdc6A, but
functions less efficiently than Xcdc6A.
Inhibition of Xcdc6B blocks chromosomal DNA
replication
To determine whether Xcdc6B is necessary for S phase
progression in vivo, we utilized several Xcdc6B inhibitors.
In one approach, we used morpholino anti-Xcdc6B oligos
(Xcdc6B-MOs) that targeted the 5 untranslated region of
Xcdc6B to inhibit Xcdc6B translation. To verify the func-
tionality of the Xcdc6B-MOs, we performed a number of
transfections. As anticipated, Xcdc6B protein is easily de-
tected in XTC cells that have been transfected with no
Xcdc6B-MOs (Fig. 6A, lane 1) or standard control MOs
(data not shown). In contrast, the presence of Xcdc6B-MOs
reduced the level of Xcdc6B protein in a dose-dependent
manner (Fig. 6A, top). Significantly, parallel transfections
utilizing GFP constructs indicate that our transfection effi-
ciency is35% with these cells. This moderate transfection
efficiency, coupled with the considerable reduction in
Xcdc6B signal in the presence of Xcdc6B-MOs, under-
scores the potency of this reagent. Importantly, the levels of
Xorc2 (Fig. 6A, bottom) and -tubulin (data not shown) are
unaffected by the presence of Xcdc6B-MOs, demonstrating
the specificity of this reagent.
Having established that the presence of Xcdc6B-MOs
specifically inhibits Xcdc6B protein production, we utilized
this reagent to assess whether a reduction in Xcdc6B protein
expression might inhibit S phase progression. In these ex-
periments, we microinjected synchronized XTC cells during
G1 phase, before pre-RC formation and, therefore, before
Xcdc6B activity. To detect microinjected cells, all micro-
injections contained nonfused GST protein and were stained
with anti-GST antibodies (Fig. 6B, middle column). Micro-
injection of GST alone or control MOs had little to no effect
on S phase progression, as assessed by BrdU uptake. In
contrast, cells injected with Xcdc6B-MOs exhibited signif-
icantly reduced S phase entry (Fig. 6B and C). Since MOs
inhibit protein translation, an important additional control
was to coinject both Xcdc6-MOs along with recombinant
Xcdc6B protein. As predicted, the presence of recombinant
Xcdc6B in this coinjection negated much of the Xcdc6-MO
inhibition and restored S phase entry (Fig. 6B and C).
Finally, we performed an additional microinjection ex-
periment to inhibit Xcdc6B activity by an independent
means. Specifically, we investigated whether parallel mi-
croinjections of anti-Xcdc6B antibodies might also inhibit S
phase progression. Like the Xcdc6B-MOs injections, cells
microinjected with anti-Xcdc6B antibodies were inhibited
in their ability to enter S phase relative to control injections
(Fig. 6B and C). Together, these data demonstrate that
inhibition of either Xcdc6B protein production or Xcdc6B
activity block chromosomal DNA replication in somatic
cells.
Fig. 4. Endogenous Xcdc6B does not bind sperm chromatin in the early
embryo. Immunoblots were performed on purified GST-Xcdc6B protein
(10, 5, 2.5, 1.25 ng; lanes 1–4, respectively) or detergent insoluble frac-
tions isolated from sperm nuclei which had been incubated in interphase
egg extracts at 23°C for the indicated times (lanes 5–7). Samples were
prepared for immunoblot analysis using anti-Xorc2 (top), anti-Xcdc6A
(middle), or anti-Xcdc6B (bottom) antibodies. As in Fig. 3C, each lane
represents 2  105 nuclei.
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Fig. 5. Xcdc6B binds chromatin and restores DNA replication to a Xcdc6-depleted egg extract. (A) Replication of sperm chromatin was determined in
Xcdc6-depleted (lanes 1–15) or mock depleted (lanes 16–18) interphase extracts in the presence of control buffer (lanes 1–3; 16–18), purified GST-Xcdc6A
(80 nM, lanes 4–6; 20 nM, lanes 10–12), or GST-Xcdc6B (80 nM, lanes 7–9; 20 nM, lanes 13–15). Each lane depicts the 32P incorporation into chromosomal
DNA that occurred during the following times: 1-45 min (lanes 1, 4, 7, 10, 13, 16), 46-90 min (lanes 2, 5, 8, 11, 14, 17), and 91-105 min (lanes 3, 6, 9, 12,
15, 18). (B) Quantitation of the total chromosomal DNA replication for the indicated samples shown in part A over a 105-min period in either a mock depleted
extract in the presence of control buffer alone (bar e) or Xcdc6-depleted extract in the presence of GST-Xcdc6A (bars a and c) or GST-Xcdc6B (bars b and
d) at the indicated protein concentrations. In this analysis, we have subtracted the background (replication which occurred in a Xcdc6 depleted extract plus
control buffer) and defined 100% as the amount of replication that occurred in a mock depleted extract in the presence of control buffer. (C) Immunoblots
were performed on detergent-insoluble fractions isolated from Xcdc6-depleted interphase extracts containing chromatin incubated in the presence of control
buffer (lanes 1–3), 80 nM GST-Xcdc6B (lanes 4–6), or 80 nM GST-Xcdc6A (lanes 7–9). Samples were incubated at 23°C for the indicated times and
prepared for immunoblot analyses by using anti-Xorc2 (top), anti-Xcdc6A (second panel), anti-Xcdc6B (third panel), or anti-Xmcm3 (bottom) antibodies.
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Discussion
In this study, we have identified a novel developmental
control process in Xenopus Cdc6 regulation. Specifically,
we have discovered that there are two Xcdc6 isoforms that
are differentially regulated during development. As de-
scribed herein, the originally isolated Xcdc6 isoform, now
designated Xcdc6A, is dramatically downregulated follow-
ing MBT. We have identified and characterized a second
Xcdc6 isoform, designated Xcdc6B, which replaces
Xcdc6A in somatic tissue. These two classes of Cdc6 are
encoded by different genes and their divergence localizes
primarily to the noncoding regions and the proposed regu-
latory N-terminal one-third of the protein coding region.
While Xcdc6B protein is present in the early embryo, it does
not appear to be functional at these stages. In somatic cells,
however, both the expression pattern and activity (e.g.,
ability to bind chromatin) of Xcdc6B change in a cell
cycle-dependent manner. Moreover, inhibition of either
Xcdc6B translation or activity represses S phase progres-
sion in somatic cells. Thus, Xcdc6A appears to be the only
functional Cdc6 present during early embryogenesis, while
Xcdc6B is the sole isoform functioning later in develop-
ment. Collectively, our data reveal a previously unappreci-
ated developmental complexity in Cdc6 regulation that may
contribute to the dramatic cell division cycle remodeling
known to occur during Xenopus development.
The data presented here demonstrate that the two Xcdc6
isoforms undergo transcriptional, translational, and post-
translational regulation. The mRNAs of both Xcdc6A and
Xcdc6B are present in the early embryo: the former be-
comes undetectable following stage 40, while the latter is
present throughout development and in adult tissue. At the
protein level, both isoforms are present in the early embryo,
but only Xcdc6A appears to function. Interestingly, Xcdc6A
protein levels remain constant during the early embryonic
Fig. 6. Inhibition of Xcdc6B blocks entry into S phase in somatic cells. (A) Immunoblots were performed on XTC cells lysates (50 g total protein per lane)
following transfection in the absence (lane 1) or presence Xcdc6B-MOs (lanes 2–3; 0.5 and 5 g Xcdc6-MO, respectively) by using anti-Xcdc6B (top) or
anti-Xorc2 (bottom) antibodies. (B) Immunofluorescence analysis of XTC cells that were microinjected in G1 and stained for total DNA (left column),
microinjection status (middle column), or entry into S phase (right column). Microinjecting GST (to facilitate detection of injected cells) with either
Xcdc6B-MOs (third row) or anti-Xcdc6B antibodies (fifth row) inhibited entry into S phase as indicated by decreased BrdU staining (arrows). Control
experiments microinjecting GST alone (first row), standard control MOs (second row), or Xcdc6B-MOs in the presence of recombinant Xcdc6B (fourth row)
show reduced or no effect on S phase entry. Cells marked with an asterisk represent the range classified as / intensity; intensities above this level are
considered /, intensities below this level are /. (C) Quantitation of S phase progression for the microinjection experiments shown in part B.
Microinjected cells (GST positive) were evaluated for entry into S phase (BrdU-positive) by scoring as either bright staining (/), intermediate-staining
(/), or nonstaining (/), see above. Each bar represents the average of experiments where the number of microinjected cells was 250.
372 N. Tikhmyanova, T.R. Coleman / Developmental Biology 260 (2003) 362–375
cell cycles, while Xcdc6B protein levels plummet following
mitosis during somatic cell cycles. This degradation of
Xcdc6B may reflect the fact that Xcdc6B possesses an intact
KEN box, while Xcdc6A does not. Since an intact KEN box
is essential for degradation (Pfleger and Kirschner, 2000),
its presence in Xcdc6B suggests that this protein, like mam-
malian Cdc6 (Petersen et al., 2000), may be an APC-Cdh1
substrate.
Following gastrulation, Xcdc6B is the sole isoform de-
tectable in somatic tissue. One plausible explanation for
such an expression/activity pattern would invoke that ma-
ternally derived Xcdc6A functions during the transcription-
ally inactive cleavage cycles due to a higher affinity than
Xcdc6B for the embryonic pre-RCs. Alternatively, an un-
characterized inhibitor of Xcdc6B might function in the
early embryo. If this inhibitor is complexed with Xcdc6B
and removed during immunodepletion, then recombinant
Xcdc6B could function when added back to a depleted
extract. Finally, in a third model, Xcdc6B may be inactive
in the early embryo due to low levels of activating kinase
(see below). Following MBT, both maternal Xcdc6A and
Xcdc6B are likely degraded. Of note, the destruction of
other maternal cell cycle regulators is known to occur at
approximately this time (Hartley et al., 1997; Howe et al.,
1995; Howe and Newport, 1996; Kim et al., 1999). Though
both mRNAs are present post-MBT, the onset of zygotic
transcription demarcates the switch to the exclusive expres-
sion of Xcdc6B protein. Concomitant with its replacement
of Xcdc6A, the relative mobility of Xcdc6B is altered by a
phosphorylation-mediated event. This correlation between
elongation of S phase and replacement of Xcdc6A with
phosphorylated Xcdc6B raises the possibility that these
events may be causally linked.
Does replacement of Xcdc6A with Xcdc6B account for
differential origin usage during development?
As outlined in the introduction, the number of origins of
DNA replication decreases dramatically at midblastula tran-
sition (MBT; stage 8, 5 h postfertilization), resulting in a
significant elongation in S phase. As the cell division cycle
of frogs and flies progresses from early embryonic to that
typical of proliferating cells in adult tissue, initiation site
selection changes from random to site specific (Hyrien,
1995; Sasaki et al., 1999). This change does not result from
expression of new ORC proteins since only one set of ORC
genes has been discovered in frogs and flies. Provocatively,
the downregulation of Xcdc6A and upregulation of phos-
phorylated Xcdc6B coincides temporally with this cell di-
vision cycle reprogramming. In addition, the fact that re-
combinant Xcdc6B restores DNA replication to a Xcdc6-
depleted egg extract less efficiently than recombinant
Xcdc6A is consistent with a slower Xcdc6B-mediated so-
matic-like S phase, wherein fewer DNA replication origins
fire. The magnitude of this difference in Xcdc6A/B activity,
however, cannot account for the elongation in S phase
observed in somatic tissue in vivo. Indeed, given the com-
plexity of the cell division cycle remodeling which occurs at
this transition, it is unlikely that the activity of any single
protein can fully account for the changes therein. This
developmental Xcdc6 isoform switch is likely only one of
many factors that contribute to the elongation in somatic S
phase. For example, a developmentally regulated minichro-
mosome maintenance (MCM) gene, zygotic mcm6
(zmcm6), which is expressed only after gastrulation, has
been identified (Sible et al., 1998). Xcdc6B may collaborate
with zMCM6 and potentially other unknown zygotic mem-
bers of the pre-RC and/or zygotic cell cycle regulators to
remodel origin firing and transition to a somatic S phase.
Different cell types achieve similar Cdc6 regulation
through different means
Cdc6 is not only an essential component of the DNA
replication machinery but also a key regulator of S phase
progression. Interestingly, different cell types appear to reg-
ulate their respective Cdc6 orthologs through different
means. For example, the Xenopus developmental Cdc6 iso-
form switching we report herein may be unique to this
organism since inspection of available genomic databases
revealed that multiple Cdc6 isoforms are not present in
humans, fruit flies, puffer fish, or worms (data not shown).
Since X. laevis displays features of an ancestral tetraploid
species (with a genome duplication 30 million years ago)
that has since become diploidized (Graf and Kobel, 1991),
it contains multiple copies of many genes. While many of
the related genes are functionally redundant, we demon-
strate here that Xcdc6A and Xcdc6B are not. Interestingly,
Xenopus tropicalis, which is diploid and never passed
through a tetraploid stage, appears to contain multiple Cdc6
isoforms but these tropicalis isoforms are 95% identical
and do not partition into Xcdc6A and Xcdc6B classes, but
rather are both slightly more similar to Xcdc6B.
Why two functionally distinct Cdc6 isoforms with inde-
pendent temporal partitioning and distinct activities/regula-
tion exist in Xenopus while other metazoans possess a single
gene remains unclear. It is likely, however, that this striking
regulation of Cdc6 in Xenopus reflects the pivotal impor-
tance Cdc6 plays in regulating S phase progression in all
eukaryotes. Indeed, this is not the first example of differen-
tial regulation of Cdc6 orthologs in different organisms. For
example, while both yeast and metazoans downregulate
Cdc6 activity through CDK-mediated phosphorylation dur-
ing early S phase, they achieve this downregulation in
different ways. In yeast, phosphorylated Cdc6 is degraded
in a SCF-dependent manner (Drury et al., 1997; Elsasser et
al., 1999; Jallepalli et al., 1998; Piatti et al., 1995) , while
phosphorylation of metazoan Cdc6 promotes its export from
the nucleus into the cytoplasm (Jiang et al., 1999; Petersen
et al., 1999; Saha et al., 1998). A similar divergence in Cdc6
regulation occurs within metazoans. That is, although phos-
phorylation appears to control the subcellular localization of
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both HsCdc6 and Xcdc6, the activities of these proteins vary
dramatically. Over expression (Jiang et al., 1999) or micro-
injection (Herbig et al., 2000) of unphosphorylatable
HsCdc6 inhibits DNA replication. In contrast, unphospho-
rylatable Xcdc6 not only fails to act as a dominant negative
inhibitor, but is fully functional (Pelizon et al., 2000).
The results presented here suggest that similar diver-
gence of Cdc6 regulation may occur between embryonic
and somatic cell types within the same organism. X. laevis
accomplishes this regulation through use of two distinct
Cdc6 isoforms, while other species likely accomplish the
same developmental regulation through differential modifi-
cation of a single isoform. Relatedly, DePamphilis and
coworkers have recently shown that unlike embryonic chro-
matin, which loads ORC in a Cdc6-independent manner,
somatic chromatin requires Cdc6 to load ORC (Sun et al.,
2002). It is likely, therefore, that additional differential
embryonic and somatic Cdc6 regulation will be revealed
with further work.
What alters Xcdc6B activity during development?
An intriguing finding from this study is that Xcdc6B is
present in the early embryo at relatively high levels (45
nM) and yet does not appear to function, as evidenced by its
inability to bind chromatin in the egg extract. Significantly,
when we remove both Xcdc6A and Xcdc6B from a Xenopus
egg extract and add back only GST-Xcdc6B, GST-Xcdc6B
binds chromatin and DNA replication is restored. Thus,
Xcdc6B can function in the early embryo, albeit at lower
efficiency than GST-Xcdc6A. Notably, when Xcdc6B is
present as the sole Xcdc6 isoform, it exists predominantly as
a phosphorylated, slower migrating 63-kDa form. The in-
ability of Xcdc6B to function in the early embryo, therefore,
may result from the absence of sufficient Xcdc6B modifiers
which serve to activate the protein. The exact mechanism(s)
governing Xcdc6B activity during development will require
further experimentation.
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